Dietary polyunsaturated fatty acids and the Pro12Ala polymorphisms of PPARG regulate serum lipids through divergent pathways: a randomized crossover clinical trial

详细信息    查看全文

• 作者：Jussi Pihlajam?ki ; Ursula Schwab ; Dorota Kaminska ; Jyrki ?gren…
• 关键词：PPARG ; Randomized clinical trial ; Serum triglycerides ; Dietary fat ; Human
• 刊名：Genes & Nutrition
• 出版年：2015
• 出版时间：November 2015
• 年：2015
• 卷：10
• 期：6
• 全文大小：475 KB
• 参考文献：Agren JJ, Julkunen A, Penttila I (1992) Rapid separation of serum lipids for fatty acid analysis by a single aminopropyl column. J Lipid Res 33:1871-876PubMed
  Alsaleh A, O’Dell SD, Frost GS, Griffin BA, Lovegrove JA, Jebb SA, Sanders TA, RISCK Study investigators (2011) Interaction of PPARG Pro12Ala with dietary fat influences plasma lipids in subjects at cardiometabolic risk. J Lipid Res 52:2298-303PubMed Central CrossRef PubMed
  AlSaleh A, Sanders TA, O’Dell SD (2012) Effect of interaction between PPARG, PPARA and ADIPOQ gene variants and dietary fatty acids on plasma lipid profile and adiponectin concentration in a large intervention study. Proc Nutr Soc 71:141-53CrossRef PubMed
  Altshuler D, Hirschhorn JN, Klannemark M, Lindgren CM, Vohl MC, Nemesh J, Lane CR, Schaffner SF, Bolk S, Brewer C, Tuomi T, Gaudet D, Hudson TJ, Daly M, Groop L, Lander ES (2000) The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 26:76-0CrossRef PubMed
  Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc 57:289-00
  Bouchard-Mercier A, Godin G, Lamarche B, Perusse L, Vohl MC (2011) Effects of peroxisome proliferator-activated receptors, dietary fat intakes and gene-diet interactions on peak particle diameters of low-density lipoproteins. J Nutrigenet Nutrigenomics 4:36-8CrossRef PubMed
  Cornelis MC, Hu FB (2012) Gene-environment interactions in the development of type 2 diabetes: recent progress and continuing challenges. Annu Rev Nutr 32:245-59CrossRef PubMed
  Deeb S, Fajas L, Nemoto M, Pihlajam?ki J, Mykk?nen L, Kuusisto J, Laakso M, Fujimoto W, Auwerx J (1998) A Pro12Ala substitution in the human peroxisome proliferator activated receptor gamma 2 is associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet 20:284-87CrossRef PubMed
  Ek J, Urhammer S, S?rensen T, Andersen T, Auwerx J, Pedersen O (1999) Homozygosity of the Pro12Ala variant of the peroxisome proliferation-activated receptor-gamma2 (PPAR-gamma2): divergent modulating effects on body mass index in obese and lean Caucasian men. Diabetologia 42:892-95CrossRef PubMed
  Garaulet M, Smith CE, Hernandez-Gonzalez T, Lee YC, Ordovas JM (2011) PPARgamma Pro12Ala interacts with fat intake for obesity and weight loss in a behavioural treatment based on the Mediterranean diet. Mol Nutr Food Res 55:1771-779PubMed Central CrossRef PubMed
  Heikkinen S, Argmann C, Feige JN, Koutnikova H, Champy MF, Dali-Youcef N, Schadt EE, Laakso M, Auwerx J (2009) The Pro12Ala PPARgamma2 variant determines metabolism at the gene-environment interface. Cell Metab 9:88-8CrossRef PubMed
  Huang X, Zhao J, Zhao T (2011) Effects of peroxisome proliferator activated receptor-gamma 2 gene Pro12Ala polymorphism on fasting blood lipids: a meta-analysis. Atherosclerosis 215:136-44CrossRef PubMed
  Huyghe JR, Jackson AU, Fogarty MP, Buchkovich ML, Stancakova A, Stringham HM, Sim X, Yang L, Fuchsberger C, Cederberg H, Chines PS, Teslovich TM, Romm JM, Ling H, McMullen I, Ingersoll R, Pugh EW, Doheny KF, Neale BM, Daly MJ, Kuusisto J, Scott LJ, Kang HM, Collins FS, Abecasis GR, Watanabe RM, Boehnke M, Laakso M, Mohlke KL (2012) Exome array analysis identifies new loci and low-frequency variants influencing insulin processing and secretion. Nat Genet
  Karvonen HM, Aro A, Tapola NS, Salminen I, Uusitupa MI, Sarkkinen ES (2002) Effect of alpha-linolenic acid-rich Camelina sativa oil on serum fatty acid composition and serum lipids in hypercholesterolemic subjects. Metabolism 51:1253-260CrossRef PubMed
  Kliewer SA, Sundseth SS, Jones SA, Brown PJ, Wisely GB, Koble CS, Devchand P, Wahli W, Willson TM, Lenhard JM, Lehmann JM (1997) Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma. Proc Natl Acad Sci USA 94:4318-323PubMed Central CrossRef PubMed
  Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393-03CrossRef PubMed
  Kolehmainen M, Uusitupa MI, Alhava E, Laakso M, Vidal H (2003) Effect of the Pro12Ala polymorphism in the peroxisome proliferator-activated receptor (PPAR) gamma2 gene on the expression of PPARgamma target genes in adipose tissue of massively obese subjects. J Clin Endocrinol Metab 88:1717-722CrossRef PubMed
  Lindi VI, Uusitupa MI, Lindstrom J, Louheranta A, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Tuomilehto J (2002) Association of the Pro12Ala polymorphism in the PPAR-gamma2 gene with 3-year incidence of type 2 diabetes and body weight change in the Finnish Diabetes Prevention Study. Diabetes 51:2581-586CrossRef PubMed
  Luan J, Browne PO, Harding AH, Halsall
• 作者单位：Jussi Pihlajam?ki (1) (2)
  Ursula Schwab (1) (2)
  Dorota Kaminska (1)
  Jyrki ?gren (3)
  Johanna Kuusisto (4)
  Marjukka Kolehmainen (1)
  Jussi Paananen (1)
  Markku Laakso (4)
  Matti Uusitupa (1) (5)
  
  1. Institute of Public Health and Clinical Nutrition, University of Eastern Finland, 70210, Kuopio, Finland
  2. Department of Clinical Nutrition and Obesity Center, Kuopio University Hospital, Kuopio, Finland
  3. Institute of Biomedicine, University of Eastern Finland, Kuopio, Finland
  4. Department of Medicine, Kuopio University Hospital, University of Eastern Finland, Kuopio, Finland
  5. Research Unit, Kuopio University Hospital, Kuopio, Finland
  
• 刊物主题：Human Genetics; Nutrition; Gene Function; Biomedicine general;
• 出版者：Springer Berlin Heidelberg
• ISSN：1865-3499

文摘

Human and animal studies suggest an interaction between the Pro12Ala polymorphism of PPARG and dietary fat. In this randomized crossover clinical trial, we investigated whether subjects with the Pro12Pro and Ala12Ala genotypes of PPARG respond differently to a diet supplemented with high saturated (SAFA) or polyunsaturated fatty acid (PUFA).We recruited non-diabetic men from a population-based METSIM study (including 10,197 men) to obtain men with the Ala12Ala and the Pro12Pro genotypes matched for age and body mass index. Seventeen men with the Pro12Pro genotype and 14 with the Ala12Ala genotype were randomized to both a PUFA diet and a SAFA diet for 8 weeks in a crossover setting. Serum lipids and adipose tissue mRNA expression were measured during the diet intervention. At baseline, subjects with the Ala12Ala genotype had higher levels of HDL cholesterol and lower levels of LDL cholesterol, total triglycerides, and apolipoprotein B compared to those subjects with the Pro12Pro genotype (P < 0.05, FDR < 0.1). The Ala12Ala genotype also associated with higher mRNA expression of PPARG2, LPIN1, and SREBP-1c compared to participants with the Pro12Pro genotype (FDR < 0.001). On the other hand, PUFA diet resulted in lower levels of fasting glucose, total cholesterol, total triglycerides, and apolipoprotein B (P < 0.05, FDR < 0.1) but did not affect PPARG2 mRNA expression in adipose tissue. We conclude that individuals with the Pro12Pro genotype, with higher triglyceride levels at baseline, are more likely to benefit from the PUFA diet. However, the beneficial effects of dietary PUFA and the Ala12Ala genotype of PPARG on serum lipids are mediated through divergent mechanisms. Keywords PPARG Randomized clinical trial Serum triglycerides Dietary fat Human